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Previous models of p36 based on proteolytic fragments describe the tail and core as two noninteracting domains. How- 
ever, the monoclonal antibody H28 recognizes a discontinuous epitope, which covers the peptide segments around Ser 
25 in the tail and around Glu 65 in the core of porcine ~36. Thus, the phosphorylatable Tyr 23 is much closer to the 
first consensus sequence (residues 4&62) of Caz+/lipid-binding proteins than previously thought. This apposition is in 
line with biochemical experiments indicating an influence of core ligands on tyrosine phosphorylation and an enhanced 
Ca*+ requirement of the modified p36 in phospholipid binding. 
Calpactin; Discontinuous epitope; Lipocortin; src kinase; Tyrosine phosphate 
1. INTRODUCTION 
~36, the major cytoplasmic target of src- 
encoded tyrosine-protein-kinase, is usually isolated 
as a heterotetramer with a pl 1 polypeptide [I]. The 
pl 1 dimer forces p36 into the heterotetramer com- 
plex and modulates some of the binding properties 
shown by the monomeric p36 [2-41. p36 displays 
the sequence principle characteristic for a new class 
of Ca’+/lipid-binding proteins [5]. The large core 
domain spans four homologous segments and 
displays Ca*+ as well as Ca*+-dependent lipid 
binding [6,7]. The short amino-terminal tail har- 
bors the pll-binding site and bears the tyrosine 
phosphorylation site as well as a site recognized by 
kinase C [7- 111. As tail and core domains can be 
separated by limited proteolysis [7,9], current 
models assume that the tails of two p36 molecules 
anchor to the pll dimer without further contacts 
[ 121. This view does not allow for a communica- 
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tion between the two domains of ~36. It does not 
explain why p36 phosphorylated at Tyr 23 has an 
enhanced Ca*+ requirement in lipid binding [4] and 
why tyrosine phosphorylation is enhanced in vitro 
by core ligands [ 13,141. The characterization of the 
discontinuous H28 epitope given below provides 
for an unexpected proximity of the tail domain and 
the core, which allows a direct communication. 
2. MATERIALS AND METHODS 
Porcine, bovine and chicken p36 were purified from in- 
testinal epithelium essentially as in [1,15]. Human p36 was 
isolated from placenta using the same protocol. A crude murine 
p36 fraction was obtained by extracting intestinal epithelium 
first with Triton X-100 and Ca*+ and then with EGTA [l]. 
Chymotryptic, tryptic and V8 protease cores of porcine p36 
were obtained by mild proteolysis [15]. The in situ proteolysis 
derivative p34 [7], murine monoclonal antibody H28 [16] and 
rabbit antibodies to porcine p36 [l] have been described. 
Automated gas-phase sequencing (Applied Biosystems model 
470A) was performed on the chymotryptic cores of porcine and 
chicken p36 and on N-terminal peptides. Western blots were 
usually treated with H28 and the second antibody at 37°C to 
conform with the previous immunofluorescence microscopical 
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data [16]. Competitive immunoblots were at room temperature. 
For carboxylate modification porcine p36 was treated with 1 M 
glycine methyl ester and 30 mM EDC [l-ethyl-3-(NJ+ 
dimethyl)aminopropylcarbodiimide] in 0.1 M Mes (pH 5.4). 
The reaction was stopped after 30 and 90 min with 1 M sodium 
acetate (pH 5.4). Subsequent treatment with hydroxylamine 
was used to ensure reversion of a possible tyrosine modifica- 
tion. p36 was cleaved with CNBr using standard procedures. 
Fragment fi was separated from other peptides by gel 
chromatography in 9 M urea, 100 mM NaCl, 20 mM Tris-HCl 
(pH 7.4), 3 mM DTT on an S200 column (Pharmacia). The 
fragment was renatured [2] by dialysis against 20 mM Tris-HCI 
(pH 7.4), 100 mM NaCl, 1 mM NaN3, 0.5 mM EGTA, 2 mM 
DTT. The blocked N-terminal end and the amino acid composi- 
tion identified fragment fr as spanning residues 1-l 17. 
3. RESULTS 
H28 antibody reacts strongly in Western blots 
with porcine, chicken and bovine p36 purified 
from intestinal epithelium (fig. 1C). No reaction 
was observed with human p36 purified from 
placenta or the murine p36 present in an extract of 
intestinal cells. In order to map the epitope several 
proteolytic derivatives of porcine ~36, which 
lacked increasing numbers of N-terminal residues, 
were used in Western blos (fig.lA). While the V8 
protease core starting at Gly 14 harbors the H28 
epitope, no antibody reactivity was found with the 
tryptic and chymotryptic cores, which begin with 
Ala 28 and Thr 30, respectively. A proteolysis 
product of molecular mass 34 kDa obtained as a 
by-product during protein I purification [7] also 
bound H28. Automated sequencing of this 
material revealed an equimolar mixture of core 
molecules starting at Ser 25 and Ala 28, respective- 
ly. In standard proteolysis experiments [7] H28 in- 
hibited the cleavage of porcine p36 observed by 
chymotrypsin or trypsin. 
The results on the different core derivatives in- 
dicate that the region starting at Ser 25 forms part 
of the H28 antibody-binding site. If this site forms 
a continuous linear epitope, the sequences of p36 
from different species should explain the limited 
cross-reactivity of H28 observed (fig. 1) by obvious 
amino acid replacements. However, the H28-re- 
active bovine protein and the non-reactive human 
protein show no amino acid replacement between 
residues 1 and 64 ([17,18] see fig.2). Thus, the 
epitope must involve an additional region. In the 
further characterization of this discontinuous 
(conformational) epitope, we were greatly helped 
by the currently available p36 sequences. Since 
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human and bovine p36 differ by only 5 
replacements, we analyzed additional fragments of 
porcine p36 for H28 binding. Reactivity was re- 
tained on residues 1-212 obtained by cleavage at 
the single tryptophan [7]. More importantly, im- 
mobilized H28 absorbed from the total mixture of 
CNBr fragments the large N-terminal fragment ft, 
which spans residues l-l 17 (figs lB,3A). Within 
this region human and bovine p36 differ only at 
position 65. Therefore, we extended our previous 
sequence data [7] on porcine ~36. The chymotryp- 
tic core was sequenced until Gln 68. As shown in 
fig.2 the H28-positive proteins from cow and pig 
show identical sequences for residues 21-68, while 
the immunologically distinct human protein shows 
a single amino acid exchange, i.e. Glu 65 is re- 
placed by Ala. To consolidate this deduction, we 
determined the N-terminal 69 residues of chicken 
A El C 
Ix= - _ A 
~36 _ - ~l-c,#l@ 45 
IC=- - 
abcdef a bed a bed efg 
Fig.1. H28 reactivity of porcine p36 requires part of the N- 
terminal tail domain. The upper and lower part of panel A show 
gel patterns and corresponding Western blots of porcine p36 
(lanes a,e), the p34 in situ proteolysis product (lane f) and two 
purified core domains. Note the loss of the epitope in the 
chymotryptic core (lane d) and its presence in the V8 protease 
core (lane c). In mildly trypsinized p36 (lane b), reactivity is 
restricted to undigested material (top band) and lost in the core 
domains starting either at Ala 28 (middle band) or at a yet 
unidentified residue (bottom band in upper part). Immunopre- 
cipitations with H28 are shown in B (lanes a,c). hc and lc 
designate the IgG heavy and light chains, respectively. Experi- 
ments were performed on an EGTA extract from bovine 
MDCK cells (lane a) or with CNBr-treated porcine p36 (lane c). 
Lane b shows the larger fragments fi and fz prior to immuno- 
precipitation. Note that H28 absorbs specifically the I2 kDa N- 
terminal fragment f, (lane c), while fz remains non-bound (slot 
d). The limited cross-species reactivity of H28 is shown in panel 
C by gel patterns (lanes a-d, upper part) and corresponding 
Western blots (lower part) of porcine (lanes a), human (lanes b), 
chicken (lanes c) and bovine p36 (lanes d). In a crude extract of 
mouse intestinal cells (lane e) a polyclonal antibody detects 
murine p36 (lane f), but H28 does not (lane g). 
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Fig.2. The N-terminal sequences of p36 from 5 different species. Sequences for murine, bovine and human p36 have been deduced 
from cDNA clones [5,17,18]. Protein sequences of porcine and chicken p36 are based on automated sequencing of the core domains 
and characterization of the N-terminal peptides. Only the variant positions vs bovine p36 are given. Note the presence of a glutamic 
acid residue at position 65 in the H28-positive proteins from pig, cow and chicken and the change to alanine (human) and valine 
(mouse) in the non-reactive proteins. X denotes an as yet unidentified residue in porcine ~36. Over the region shown, the non-reactive 
human p36 differs only at position 65 from the reactive bovine ~36. Arrows indicate the two peptide segments proposed for the 
discontinuous epitope. The horizontal line indicates the consensus sequence of Ca*+/lipid-binding proteins. Identified phosphorylation 
sites are designated by asterisks (see text). 
~36, which also harbors the H28 epitope (fig.lC). 
Although the avian protein differs by several con- 
servative replacements from the mammalian pro- 
teins, it displays Glu 65 as do the other two 
H28-reactive proteins (fig.2). Three replacements 
in chicken p36 locate directly in or close to the first 
part of the epitope deduced above. They involve 
the substitution of an alanine for a glycine (posi- 
tion 24), a threonine for a serine (position 25) and 
a serine for a threonine (position 30). All three 
substitutions are highly conservative replacements. 
The amino acid requirements of the H28 epitope 
also explain its absence in murine p36 (fig.lC). As 
in the non-reactive human ~36, Glu 65 is replaced 
by an uncharged residue. This is a valine for 
murine p36 [5] and an alanine for the human pro- 
tein [ 181. Given the importance of Glu 65 for H28 
reactivity porcine p36 was treated with glycine 
methyl ester and EDC to esterify the acidic 
residues at the protein surface. Fig.3A shows that 
the chemical modification abolished antigenicity in 
a subsequent blot. In addition, esterified p36 was 
not precipitated by H28 antibody (not shown). 
After a similar EDC treatment of porcine p36 com- 
plexed with H28 antibody reactivity of p36 was 
preserved when the separated polypeptides were 
probed with H28 on an immunoblot (fig.3A). 
To compare the relative affinities of the dif- 
ferent proteins for H28 immobilized porcine p36 
was probed with solutions containing a constant 
amount of antibody and increasing concentrations 
of a competing antigen (fig.3B). In this assay por- 
cine p36 showed at least a 200-fold higher affinity 
for H28 than the human protein. The N-terminal 
CNBr fragment fi of porcine p36 showed about 
13-fold lower affinity than the intact protein. The 
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Fig.3. (A) Gels (upper part) and corresponding blots (lower 
part) of porcine p36 treated for 15 min (lanes a,b) or 90 min 
(lanes c,d) with EDC in the absence (lanes a,c) or presence of 
H28 antibody (lanes b,d). Note the loss of H28 reactivity upon 
EDC treatment in the subsequent blot (lanes a,c, lower part) 
and the protection of the epitope in the presence of H28 (lanes 
c,d, lower part). In panel B a constant amount of porcine p36 
was blotted on nitrocellulose. Blots were then treated with an 
H28 antibody concentration of approx. 5 nM in the presence of 
added human p36 (part a), porcine p36 CNBr fragment fi (part 
b) and porcine p36 (part c). Blots were subsequently washed and 
treated with a peroxidase-labelled second antibody. In lane 1 
the concentration of human and porcine antigen was 3 pM, that 
of the fi fragment being 2.5 ,uM. Lanes 2-7 show the results 
when the competing antigen was diluted by factors of 3,6.5, 30, 
300, 3000 and 300000, respectively. Note the very poor 
competition by human p36 in slots 6 and 7 of a vs the good 
competition with porcine p36 (slots 4-7 of c) and the 
competition by the CNBr fragment. Panel C shows a gel of the 
porcine p36 N-terminal CNBr fragment (fi), purified by gel 
filtration, which was used for the competition in panel B 
(part b). 
decreased affinity of the fragment could be due 
either to imperfect refolding or to the presence of 
an as yet unidentified third peptide segment in the 
H28 epitope. 
203 
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4. DISCUSSION 
Several studies using proteins of known three- 
dimensional structure have shown that the majori- 
ty of antibodies elicited involve discontinuous 
epitopes. These consist of several peptide segments 
brought together by the correct folding. Identifica- 
tion of discontinuous epitopes is often helped by 
the limited cross-species reactivity of monoclonal 
antibodies due to known amino acid replacements 
arising in a series of homologous proteins (review 
[19]). In line with this concept, the H28 epitope 
provides the first information on the folding of 
~36. The epitope combines the peptide segment 
around Ser 25, located in the tail domain, with the 
peptide segment around Glu 65 located in the core 
domain. Thus, previous models describing tail and 
core as two non-interacting domains [ 121 are clear- 
ly oversimplifications. 
An interesting aspect of the H28 epitope con- 
cerns the potential influence of tyrosine 
phosphorylation on established properties of ~36. 
Tyr 23 and Ser 25, the targets of src-kinase and 
kinase C, respectively [9-l 11, are situated close to 
or within an epitope, which also covers Glu 65. In- 
terestingly, the latter residue follows the Geisow 
consensus sequence [20] in the first core segment 
(residues 46-62, fig.2). Related sequences are pre- 
sent in a similar relative location in all 4 core 
segments of the Ca’+/lipid-binding proteins 
[5,17,18]. Thus, the phosphorylation sites are in a 
much closer proximity with a unique consensus se- 
quence, believed to be involved in Ca2+ and/or 
phospholipid binding [20], than previously an- 
ticipated. Interestingly, tyrosine-phosphorylated 
p36 has a higher Ca2+ requirement for lipid 
binding than unmodified p36 [4] and tyrosine 
phosphorylation of p36 by src-kinase is markedly 
enhanced by Ca2+ and phospholipids [ 131. While 
these results cannot be explained by previous 
models, they fit the view developed by the 
characterization of the discontinuous H28 epitope. 
The N-terminal 12 residues of p36 form as an cy- 
helix the major binding site of p36 for the pll 
molecule [15]. In line with this restriction of the 
major pll-binding site to the N-terminal half of 
the tail, H28 antibody binds to p36 as well as to 
p36 complexed with pll (not shown). As the 
p36/pll heterotetramer has a lower Ca2+ require- 
ment for lipid binding than p36 [3,4], we speculate 
that the sequence around residue 25 could bring 
the pl l-binding site with its pll ligand into apposi- 
tion with the Ca’+/lipid-binding site. 
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